Triple negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer characterized by the absence of expression of estrogen receptor (ER), progesterone receptor (PgR) and human epidermal growth factor receptor-2/neu (HER-2). Here, ESR1 is linked to breast carcinoma.